CVS Health Corporation (CVS) Financial Statements (2024 and earlier)

Company Profile

Business Address ONE CVS DR.
WOONSOCKET, RI 02895
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13,08911,45516,18816,88717,72015,723
Cash and cash equivalents9,8018,19613,04313,80714,61812,945
Short-term investments3,2883,2593,1453,0803,1022,778
Receivables32,21735,22732,92729,54628,33127,276
Inventory, net of allowances, customer advances and progress billings16,34618,02517,95417,29118,26319,090
Inventory16,34618,02517,95417,29118,26319,090
Disposal group, including discontinued operation    620625908
Other current assets5,8213,1513,0743,4123,7672,685
Total current assets:67,47367,85870,14367,75668,70665,682
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization  1,229    
Operating lease, right-of-use asset17,04517,25217,56417,70317,66017,872
Property, plant and equipment   13,02213,00112,87212,873
Long-term investments and receivables24,07423,01921,66722,11421,61221,096
Long-term investments24,07423,01921,66722,11421,61221,096
Intangible assets, net (including goodwill)120,042120,506120,885121,378110,425102,904
Goodwill91,27291,27291,26191,26084,05778,150
Intangible assets, net (excluding goodwill)28,77029,23429,62430,11826,36824,754
Restricted cash and investments255239236233230216
Other noncurrent assets4,8014,6604,8254,8524,8244,620
Other undisclosed noncurrent assets16,05314,9652,9643,0343,0013,012
Total noncurrent assets:182,270181,870181,163182,315170,624162,593
TOTAL ASSETS:249,743249,728251,306250,071239,330228,275
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities36,06737,08637,44536,19834,04233,583
Accounts payable13,71714,89714,87413,36712,52714,838
Accrued liabilities22,35022,18922,57122,83121,51518,745
Deferred revenue11714916716113671
Debt6,4502,9722,1322,4021,7781,778
Disposal group, including discontinued operation    208213228
Other undisclosed current liabilities40,68538,98241,80940,23738,88534,076
Total current liabilities:83,31979,18981,55379,20675,05469,736
Noncurrent Liabilities
Long-term debt and lease obligation, including:57,69458,63859,78261,41956,45050,476
Finance lease, liability  1,325   1,406
Other undisclosed long-term debt and lease obligation57,69457,31359,78261,41956,45049,070
Liabilities, other than long-term debt26,13126,55626,92827,51827,33727,412
Deferred income tax liabilities4,1844,3114,2504,5884,0953,880
Other liabilities6,2056,2116,2376,3216,6716,732
Operating lease, liability15,74216,03416,44116,60916,57116,800
Other undisclosed noncurrent liabilities8,4498,7098,5338,9268,9099,336
Total noncurrent liabilities:92,27493,90395,24397,86392,69687,224
Total liabilities:175,593173,092176,796177,069167,750156,960
Equity
Equity, attributable to parent, including:73,96876,46174,33772,72671,38271,015
Common stock181818181818
Treasury stock, value(36,773)(33,838)(33,831)(33,933)(33,802)(31,858)
Accumulated other comprehensive loss(341)(297)(1,004)(858)(875)(1,465)
Retained earnings61,87361,60460,34358,86857,75356,145
Other undisclosed equity, attributable to parent49,19148,97448,81148,63148,28848,175
Equity, attributable to noncontrolling interest182175173276198300
Total equity:74,15076,63674,51073,00271,58071,315
TOTAL LIABILITIES AND EQUITY:249,743249,728251,306250,071239,330228,275

Income Statement (P&L) ($ in millions)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Revenues88,43793,81389,76488,92185,27883,846
Premiums earned, net30,39125,07524,65725,10824,35221,436
Cost of revenue(75,208)(52,151)(85,460)(84,549)(81,038)(78,686)
Cost of goods and services sold(48,073)(57,419)(54,688)(53,536)(51,455) 
Policyholder benefits and claims incurred, net      
Gross profit:13,22941,6624,3044,3724,2405,160
Operating expenses(10,958)(38,289)(614)(1,138)(794)(1,542)
Operating income:2,2713,3733,6903,2343,4463,618
Nonoperating income
(Other Nonoperating income)
252222222243
Interest and debt expense(716)(690)(693)(686)(589)(552)
Income from continuing operations before income taxes:1,5802,7053,0192,5702,8793,109
Income tax expense(456)(658)(754)(656)(737)(809)
Net income:1,1242,0472,2651,9142,1422,300
Net income (loss) attributable to noncontrolling interest(11)(1)(4)(13)(6)2
Net income available to common stockholders, diluted:1,1132,0462,2611,9012,1362,302

Comprehensive Income ($ in millions)

6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
Net income:1,1242,0472,2651,9142,1422,300
Other comprehensive income (loss)(44)707(146)17389144
Comprehensive income:1,0802,7542,1191,9312,5312,444
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(11)(1)(4)(13)(6)2
Comprehensive income, net of tax, attributable to parent:1,0692,7532,1151,9182,5252,446

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: